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Leishmania LeIF antigen, homologous to eukaryotic initia-
tion factor eIF4A, was originally described as a Th1-type
natural adjuvant and as an antigen that induces an IL-12-
mediated Th1 response in the peripheral blood mononuc-
lear cells (PBMC) of leishmaniasis patients. We showed
previously that the induction of cytokines in monocytes of
healthy subjects is not unique to the Leishmania protein.
Indeed, 5 homologous proteins DEAD box in mammals
and yeast were also able to induce the secretion of cyto-
kines in monocytes of healthy subjects. In this study we
aimed to validate eIF4A protein as a natural adjuvant. To
achieve this objective, LeIF, eIF4A from mouse (MeIF4A)
and Yeast (YeIF4A) were expressed and purified. The puri-
fied proteins were assessed for their ability to induce
maturation of bone marrow-derived dendritic cells
(BMDC). Their effect on DCs and their monocytic precur-
sors in the peritoneal cavity of mice were analyzed. Our
data showed that eIF4A proteins were able to activate
BMDC to express co-stimulatory molecules and to pro-
duce IL-12p40/p70 and iNOS in vitro. Furthermore,
eIF4A proteins induced inflammation in the peritoneal
cavity of BALB/c mice similar to the well known adjuvant
Alum. Indeed, injection of eIF4A proteins in combination
with OVA protein induced a rapid recruitment into the
peritoneal cavity of Ly6C
high/CD11b
+ inflammatory mono-
cytes, Ly6G
high/CDb
+ neutrophils and myeloid dendritic
cells (MHC IIhigh-CD11c+). This study highlights
the adjuvant activity of eIF4A protein and suggests that
the immunomodulatory properties of eIF4A could be
exploited in vaccination or immunotherapy protocols.
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